Hi everyone

Here is the recording of our first Substack Live session. We did have some technical glitches, but it was a lot of fun to talk about the potential impact of tariffs on pharma and medical device supply chains.

My guest was Marco who writes about risk and resilience On the Edge of Resilience on his Substack. Please go check it out and subscribe.

Here are some of the key points:

* Pharma imports into the US could face up to 25% in tariffs.

* Tariffs on pharma and med device imports could be more than $60 billion.

* The impact of tariffs could lead to increased costs for consumers.

* Companies need to build capacity to handle supply chain disruptions.

* Investing in resilience should be viewed as a strategic necessity.

* The conversation around supply chain costs needs to shift to investment.

* Risk management must include both proactive and reactive strategies.

* Understanding vulnerabilities in supply chains and mitigating risks is critical.

* The medical device industry faces unique challenges in managing costs and risks.

We will do this again in future. Feel free to suggest topics of interest to you.

Join me for my next live video in the app

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe